Two genes were found highly significantly regulated: Lcn2, a potential biomarker for hepatic steatosis, damage, and inflammation [42], and Resf1, a factor regulator of epigenetics modification associated with SETDB1 [43]. This evidence concerns the gene LCN2 and fatty liver disease.